In EDS ansehen

Implementing an integrated multi‐technology platform for drug checking: Social, scientific, and technological considerations.

Gespeichert in:
Bibliographische Detailangaben
Titel: Implementing an integrated multi‐technology platform for drug checking: Social, scientific, and technological considerations.
Autoren: Wallace, Bruce, Hills, Rory, Rothwell, Jake, Kumar, Deepak, Garber, Ian, Roode, Thea, Larnder, Ashley, Pagan, Flora, Aasen, Jarred, Weatherston, Jorin, Gozdzialski, Lea, Ramsay, Margo, Burek, Piotr, Azam, Md. Shafiul, Pauly, Bernie, Storey, Margaret‐Anne, Hore, Dennis
Quelle: Drug Testing & Analysis; Apr2021, Vol. 13 Issue 4, p734-746, 13p
Abstract: The illicit drug overdose crisis in North America continues to devastate communities with fentanyl detected in the majority of illicit drug overdose deaths. The COVID‐19 pandemic has heightened concerns of even greater unpredictability in the drug supplies and unprecedented rates of overdoses. Portable drug‐checking technologies are increasingly being integrated within overdose prevention strategies. These emerging responses are raising new questions about which technologies to pursue and what service models can respond to the current risks and contexts. In what has been referred to as the epicenter of the overdose crisis in Canada, a multi‐technology platform for drug checking is being piloted in community settings using a suite of chemical analytical methods to provide real‐time harm reduction. These include infrared absorption, Raman scattering, gas chromatography with mass spectrometry, and antibody‐based test strips. In this Perspective, we illustrate some advantages and challenges of using multiple techniques for the analysis of the same sample, and provide an example of a data analysis and visualization platform that can unify the presentation of the results and enable deeper analysis of the results. We also highlight the implementation of a various service models that co‐exist in a research setting, with particular emphasis on the way that drug checking technicians and harm reduction workers interact with service users. Finally, we provide a description of the challenges associated with data interpretation and the communication of results to a diverse audience. [ABSTRACT FROM AUTHOR]
Copyright of Drug Testing & Analysis is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Datenbank: Complementary Index
Beschreibung
Abstract:The illicit drug overdose crisis in North America continues to devastate communities with fentanyl detected in the majority of illicit drug overdose deaths. The COVID‐19 pandemic has heightened concerns of even greater unpredictability in the drug supplies and unprecedented rates of overdoses. Portable drug‐checking technologies are increasingly being integrated within overdose prevention strategies. These emerging responses are raising new questions about which technologies to pursue and what service models can respond to the current risks and contexts. In what has been referred to as the epicenter of the overdose crisis in Canada, a multi‐technology platform for drug checking is being piloted in community settings using a suite of chemical analytical methods to provide real‐time harm reduction. These include infrared absorption, Raman scattering, gas chromatography with mass spectrometry, and antibody‐based test strips. In this Perspective, we illustrate some advantages and challenges of using multiple techniques for the analysis of the same sample, and provide an example of a data analysis and visualization platform that can unify the presentation of the results and enable deeper analysis of the results. We also highlight the implementation of a various service models that co‐exist in a research setting, with particular emphasis on the way that drug checking technicians and harm reduction workers interact with service users. Finally, we provide a description of the challenges associated with data interpretation and the communication of results to a diverse audience. [ABSTRACT FROM AUTHOR]
ISSN:19427603
DOI:10.1002/dta.3022